PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium. iwein.gyselinck@kuleuven.be.\', \'Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.\', \'Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05033-x
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33563325
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all